Founder
Amara has a background in molecular genetics from the University of Sydney and completed a fellowship in clinical genomics at a leading Australian teaching hospital. She's founding Prion Biotech to develop precision diagnostics for neurodegenerative diseases, with an initial focus on research partnerships with major Australian medical centres. The company is operating from Sydney with early grant funding.